Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada
· Delayed Price · Currency is CAD 0.0850
-0.0050 (-5.56%)
Dec 5, 2025, 3:59 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 9.78 million as of December 5, 2025. Its market cap has decreased by -68.52% in one year.
Market Cap
9.78M
Enterprise Value
8.53M
Revenue
420.81K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 9.78M, an increase of 47.23%. That is a compound annual growth rate of 10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 9.78M | -62.16% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.62B |
| dentalcorp Holdings | 2.18B |
| Green Thumb Industries | 2.07B |
| Sienna Senior Living | 1.93B |
| Extendicare | 1.76B |
| Trulieve Cannabis | 1.39B |
| Cronos Group | 1.34B |
| WELL Health Technologies | 1.02B |